SCHEMBL18818106

SCHEMBL18818106

CC(=O)C(CCCCN)NC(=O)C(C)Cc1ccccc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 2/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ MMP1 P03956 3/20 0.50
▸ MMP3 P08254 3/20 0.50
▸ MMP9 P14780 2/20 0.49
▸ GNPAT O15228 1/20 0.49
▸ MMP2 P08253 1/20 0.49
▸ ALDH1A1 P00352 1/20 0.48
▸ THRB P10828 1/20 0.48
▸ CYP2C9 P11712 1/20 0.48
▸ CYP2C19 P33261 1/20 0.48
▸ HSD17B10 Q99714 1/20 0.48
▸ ERAP2 Q6P179 2/20 0.48
▸ LNPEP Q9UIQ6 2/20 0.48
▸ ERAP1 Q9NZ08 1/20 0.48
▸ OPRK1 P41145 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ CPA1 P15085 1/20 0.47
▸ CPA2 P48052 1/20 0.47
▸ CPA4 Q9UI42 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22695988 0.88 MMP2 (0.56) MMP1MMP3MMP9GNPATMMP2
SCHEMBL16856622 0.88 MMP2 (0.56) MMP1MMP3MMP9GNPATMMP2
SCHEMBL23128421 0.86 GNPAT (0.52) MMP1MMP3MMP9GNPATMMP2
SCHEMBL22695740 0.86 GNPAT (0.54) MMP1MMP3MMP9GNPATMMP2
SCHEMBL15948101 0.86 GNPAT (0.54) MMP1MMP3MMP9GNPATMMP2
SCHEMBL22600860 0.85 GNPAT (0.53) MMP1MMP3MMP9GNPATMMP2
SCHEMBL21503819 0.84 GNPAT (0.50) MMP1MMP3MMP9GNPATMMP2
SCHEMBL22268858 0.84 OPRK1 (0.52) MMP1MMP3MMP9GNPATMMP2
SCHEMBL22133739 0.84 GNPAT (0.52) MMP1MMP3MMP9GNPATMMP2
SCHEMBL20034953 0.84 MMP1 (0.53) MMP1MMP3MMP9GNPATMMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022115451-A1 MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE NOVARTIS AG (CH) 2022-06-02 — — WO disclosed
WO-2020236825-A2 MCL-1 INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE NOVARTIS AG (CH) 2020-11-26 — — WO disclosed
WO-2017072662-A1 ANTIBODY CONJUGATES COMPRISING TOLL-LIKE RECEPTOR AGONIST NOVARTIS AG (CH) 2017-05-04 — — WO disclosed
Send feedback